Opportunity Information: Apply for HT942526LCRPTRA
The FY26 Lung Cancer Research Program (LCRP) Translational Research Award (TRA) is a discretionary federal grant opportunity offered by the Department of the Army through USAMRAA. It is designed to fund advanced translational lung cancer research that moves beyond early discovery and actively pushes promising concepts toward real-world clinical use. In practical terms, the program is looking for work that can take a strong scientific rationale and convert it into something that is closer to impacting patient care, such as a clinically relevant strategy, tool, intervention, or evidence that directly supports next-step clinical development.
A central requirement is that the proposed research must address at least one of the FY26 LCRP areas of emphasis. While the specific emphasis areas are not listed in the provided text, the intent is clear: applicants need to align their project with the program's stated priority topics for that fiscal year, rather than submitting general lung cancer research. This alignment is typically used to ensure the funded portfolio targets the most urgent or strategically important gaps identified by the program.
A distinctive feature of this award is that it supports a broad range of translational studies and is structured around two funding levels tied to the maturity of the proposed work. Under Funding Level 1, the program supports advanced or late-stage preclinical research as well as correlative studies. This generally fits projects that have already generated compelling foundational data and are now focused on validation, optimization, and generating evidence that strengthens readiness for clinical translation (for example, robust preclinical efficacy, biomarker validation, assay refinement, or correlative analyses linked to patient samples or existing datasets). Under Funding Level 2, the program supports pilot clinical trials of novel interventions, meaning small, early clinical studies intended to test feasibility, safety, preliminary activity, or other key signals that justify a larger, more definitive trial.
From an administrative standpoint, the opportunity is listed under Funding Opportunity Number HT942526LCRPTRA and CFDA number 12.420, within the Science and Technology and other Research and Development activity category. Eligibility is described as unrestricted, indicating the solicitation is broadly open to applicants rather than being limited to a narrow set of institution types (though specific submission requirements would still be governed by the full announcement). The original application closing date is September 2, 2026. The agency anticipates making about six awards. The award ceiling is not provided in the supplied source information, so applicants would need to consult the full funding announcement for budget limits, allowable costs, performance period details, and any constraints specific to Funding Level 1 versus Funding Level 2.
Overall, this opportunity is aimed at bridging the gap between strong late-stage research and tangible clinical application in lung cancer, with clear pathways for both advanced preclinical/correlative work and early pilot clinical testing of new interventions.Apply for HT942526LCRPTRA
- The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoW Lung Cancer Translational Research Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on 2026-05-05.
- Applicants must submit their applications by 2026-09-02. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 6 candidate(s).
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FY26 Lung Cancer Research Program (LCRP) Translational Research Award (TRA) FAQs
What is the FY26 LCRP Translational Research Award (TRA)?
The FY26 Lung Cancer Research Program (LCRP) Translational Research Award (TRA) is a discretionary federal grant opportunity offered by the Department of the Army through USAMRAA. It funds advanced translational lung cancer research intended to move beyond early discovery and push promising concepts toward real-world clinical use.
What is the main goal of this award?
The main goal is to bridge the gap between strong late-stage research and tangible clinical application in lung cancer. The program is focused on translating a strong scientific rationale into something closer to impacting patient care, such as a clinically relevant strategy, tool, intervention, or evidence that supports next-step clinical development.
What types of outcomes is the program looking for?
The opportunity prioritizes work that advances toward clinical use. Examples described in the opportunity include clinically relevant strategies, tools, interventions, or evidence that directly supports the next stage of clinical development.
Does the proposed research need to address specific priority topics?
Yes. A central requirement is that the proposed research must address at least one of the FY26 LCRP areas of emphasis. The specific emphasis areas are not listed in the provided information, but applicants are expected to align with the program's priority topics for that fiscal year rather than submitting general lung cancer research.
Are the FY26 LCRP areas of emphasis included in the provided information?
No. The provided information states that applicants must address at least one FY26 LCRP area of emphasis, but it does not list those areas. Applicants would need to consult the full announcement for the official emphasis topics.
What kinds of research does this award support?
This award supports a broad range of translational studies and is structured around two funding levels based on how mature the work is. It can support advanced/late-stage preclinical research and correlative studies, as well as pilot clinical trials of novel interventions.
What is Funding Level 1 intended to support?
Funding Level 1 supports advanced or late-stage preclinical research and correlative studies. It generally fits projects with compelling foundational data that now need validation, optimization, and evidence generation to strengthen readiness for clinical translation.
What are examples of activities that may fit Funding Level 1 (based on the description)?
Examples described include robust preclinical efficacy work, biomarker validation, assay refinement, and correlative analyses linked to patient samples or existing datasets.
What is Funding Level 2 intended to support?
Funding Level 2 supports pilot clinical trials of novel interventions. These are small, early clinical studies intended to test feasibility, safety, preliminary activity, or other key signals that justify a larger, more definitive trial.
Is this opportunity focused on early discovery research?
No. The award is intended for advanced translational research that moves beyond early discovery and actively pushes promising concepts toward clinical relevance and use.
Who is offering this grant opportunity?
The opportunity is offered by the Department of the Army through USAMRAA.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is HT942526LCRPTRA.
What is the CFDA number for this opportunity?
The CFDA number listed is 12.420.
What activity category is this opportunity listed under?
It is listed under the Science and Technology and other Research and Development activity category.
Is eligibility limited to specific institution types?
Eligibility is described as unrestricted, meaning it is broadly open to applicants rather than limited to a narrow set of institution types. Specific submission requirements would still be governed by the full announcement.
When is the application closing date?
The original application closing date is September 2, 2026.
How many awards does the agency expect to make?
The agency anticipates making about six awards.
What is the maximum award amount (award ceiling)?
The award ceiling is not provided in the supplied information. Applicants would need to consult the full funding announcement for budget limits and any constraints that apply to Funding Level 1 versus Funding Level 2.
Where can applicants find details on budget limits, allowable costs, and performance period?
The provided information notes that applicants should consult the full funding announcement for budget limits, allowable costs, performance period details, and other constraints (including any differences between Funding Level 1 and Funding Level 2).
How should applicants decide whether to apply under Funding Level 1 or Funding Level 2?
Applicants should choose the level that matches the maturity of their work. Funding Level 1 is described as appropriate for advanced/late-stage preclinical and correlative studies, while Funding Level 2 is described as appropriate for pilot clinical trials of novel interventions.
What makes this award distinct compared with general lung cancer research funding?
Based on the provided description, two distinguishing features are (1) the requirement to align with at least one FY26 LCRP area of emphasis, and (2) a strong focus on advanced translational work with defined pathways for late-stage preclinical/correlative studies and early pilot clinical testing.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Previous opportunity: DoW Tuberous Sclerosis Complex, Idea Development Award
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HT942526LCRPTRA
Applicants also applied for:
Applicants who have applied for this opportunity (HT942526LCRPTRA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoW Peer Reviewed Cancer, Clinical Trial Award Apply for HT942526PRCRPCTA Funding Number: HT942526PRCRPCTA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Peer Reviewed Cancer, Idea Award Apply for HT942526PRCRPIA Funding Number: HT942526PRCRPIA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW, Peer Reviewed Cancer, Impact Award Apply for HT942526PRCRPIPA Funding Number: HT942526PRCRPIPA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Ecological Parameters in the Forested Wetlands of Southern Florida Apply for W9126G262SOI9383 Funding Number: W9126G262SOI9383 Agency: Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $3,177,238 |
| NIJ FY25 Research and Evaluation of Policing Practices Apply for O NIJ 2025 172603 Funding Number: O NIJ 2025 172603 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
| NIJ FY25 Research and Evaluation on Youth Justice Topics Apply for O NIJ 2025 172607 Funding Number: O NIJ 2025 172607 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $4,000,000 |
| Willow Creek Reservoir Water Quality Research and Evaluation Studies Apply for W81EWF 26 SOI 0003 Funding Number: W81EWF 26 SOI 0003 Agency: Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $100,000 |
| Standards Coordination Office Curricula Development Cooperative Agreement Program Apply for 2026 NIST SCOCD 01 Funding Number: 2026 NIST SCOCD 01 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Agreement for affiliated Partner with the Hawaii-Pacific Island Cooperative Ecosystem Studies Unit Apply for G26AS00117 Funding Number: G26AS00117 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: $85,500 |
| Cooperative Agreement for affiliated Partner with the Desert Southwest Cooperative Ecosystem Studies Unit Apply for G26AS00116 Funding Number: G26AS00116 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: $499,550 |
| Cooperative Agreement for affiliated Partner with the Gulf Coast Cooperative Ecosystem Studies Unit Apply for G26AS00114 Funding Number: G26AS00114 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: $400,000 |
| NIJ FY25 Research and Evaluation of Emerging Technology Implementation and Impact for Law Enforcement Purposes Apply for O NIJ 2025 172616 Funding Number: O NIJ 2025 172616 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $3,000,000 |
| NIJ FY25 Research and Evaluation of Artificial Intelligence for Criminal Justice Purposes Apply for O NIJ 2025 172615 Funding Number: O NIJ 2025 172615 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HT942526LCRPTRA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
